Sort
82,697 grants matching “vaccine development”
Nucleic Acid-Based Nanoconstructs for the Treatment of Cancer
$2,278,098Chad A. Mirkin · Northwestern University At Chicago · U54 · FY2019 · CA
SPORE in Prostate Cancer
$2,277,704Donald J. Tindall · Mayo Clinic Rochester · P50 · FY2007 · CA
Influenza responses and repertoire in vaccination, infection and tonsil organoids.
$2,277,543Mark M Davis · Stanford University · U19 · FY2021 · AI
Biogenesis of bacterial outer membrane proteins
$2,277,504Harris Bernstein · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2025 · DK
Reversal of Immune Failure with Viral Cure in Chronic HCV Infection
$2,277,111Raymond T Chung · Massachusetts General Hospital · U19 · FY2015 · AI
Reversal of Immune Failure with Viral Cure in Chronic HCV Infection
$2,277,111Raymond T Chung · Massachusetts General Hospital · U19 · FY2016 · AI
Reversal of Immune Failure with Viral Cure in Chronic HCV Infection
$2,277,110Raymond T Chung · Massachusetts General Hospital · U19 · FY2017 · AI
A Global Syphilis Vaccine Targeting Outer Membrane Proteins of Treponema pallidum
$2,276,756Michael Anthony Moody · Duke University · U01 · FY2025 · AI
Stellenbosch University Clinical Trials Unit (SUN-CTU)
$2,276,671Mark Fredric Cotton · Stellenbosch University · UM1 · FY2020 · AI
Clinical Development of Chimp Adenovirus Vectors
$2,276,038Hildegund C. J. Ertl · Wistar Institute · U19 · FY2009 · AI
MD Anderson Cancer Center SPORE in Gastrointestinal Cancer
$2,275,719Scott Kopetz · University Of Tx Md Anderson Can Ctr · P50 · FY2019 · CA
Systems Biology to Identify Biomarkers of Neonatal Vaccine Immunogenicity
$2,275,700Ofer Levy · Boston Children'S Hospital · U19 · FY2021 · AI
Proteomics Core: Systems Biology to Identify Biomarkers of Neonatal Vaccine Immunogenicity
$2,275,700Hanno Steen · Boston Children'S Hospital · U19 · FY2021 · AI
Transcription factor regulation of CD4 and CD8 T cell effector and memory differentiation and function
$2,275,627Matthew Eugene Pipkin · University Of Florida · P01 · FY2022 · AI
Vermont Immunobioloigy/ Infectious Diseases Center
$2,275,106Ralph C. Budd · University Of Vermont & St Agric College · P20 · FY2011 · RR
SPORE in Gastrointestinal Cancers
$2,273,000Alison P Klein · Johns Hopkins University · P50 · FY2021 · CA
A vaccine design to induce protective B and T cell immunity against hepatitis C virus
$2,272,798Steven Foung · Stanford University · U19 · FY2024 · AI
The Military HIV Research Program (MHRP) Clinical Trial Unit
$2,272,671Merlin L Robb · Henry M. Jackson Fdn For The Adv Mil/Med · UM1 · FY2021 · AI
SPORE in Brain Cancer
$2,272,282Duke University · P50 · FY2005 · CA
Immunotherapy of low grade lymphoid malignancies
$2,271,399Adrian U Wiestner · National Heart, Lung, And Blood Institute · ZIA · FY2025 · HL
Specific and Broadly Active Monoclonal Antibody Therapeutics Against The Filoviruses
$2,270,866Erica Ollmann Saphire · La Jolla Institute For Immunology · U19 · FY2023 · AI
Resistance to MTB infection in HIV infected individuals in Uganda and S. Africa
$2,270,572W. Henry Henry Boom · Case Western Reserve University · R01 · FY2019 · AI
HIV Subtype C Alphavirus Vaccine Design &Development
$2,270,241Alphavax Human Vaccines, Inc. · U01 · FY2002 · AI
Research Project 3: Rapid-Response Roadmap for RNA vaccines
$2,270,214Jesse Hong-Sae Erasmus · Albert Einstein College Of Medicine · U19 · FY2025 · AI
IMMUNE MECHANISMS CONTROLLING INFLAMMATION AND CANCER
$2,270,149Dartmouth College · P20 · FY2002 · RR